NIAID-funded study could offset harsh effects of antibiotics.
Researchers at Memorial Sloan Kettering Cancer Center have shown that autologous fecal microbiota transplantation (auto-FMT) is a safe and effective way to help replenish beneficial gut bacteria in cancer patients who require intense antibiotics during allogenic hematopoietic stem cell transplantation. In their study, patients who underwent the procedure were randomly assigned into two groups: one group received standard care and the other received auto-FMT. The researchers found that auto-FMT resulted in the recovery of beneficial gut bacteria to near baseline levels within days, thus restoring patients’ digestive, immune and other essential functions. With standard care, beneficial bacteria typically take many weeks to recover from antibiotic treatment, leaving patients at risk of other infectious diseases, including Clostridium difficile.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, provided funding for part of the project. The study report appears in Science Translational Medicine.
“This important study suggests that clinical intervention using auto-FMT can safely reverse the disruptive effects of broad-spectrum antibiotic treatment,” says NIAID Director Anthony S. Fauci, M.D. “If validated in larger studies, this approach may prove to be a relatively simple way to quickly restore a person’s healthy microbiome following intensive antimicrobial therapy.”
Allogenic hematopoietic cell transplantation involves a donor — often but not exclusively a family member — who gives the recipient stem cells that re-establish bone marrow production of blood cells and immune function to combat cancer. Antibiotics are essential to prevent bacterial infections in stem cell recipients. However, antibiotics also destroy beneficial bacteria that enhance immune function and resistance to infection. The loss of beneficial bacteria increases the risk of certain life-threatening infectious diseases and graft-versus-host disease (GVHD).
The study involved cancer patients who provided their own fecal sample, which was frozen and stored prior to their cell transplantation procedure. Weeks later, when physicians confirmed that the transplanted cells were growing, they assessed the status of the patients’ beneficial gut bacteria. The first 25 patients who lacked known beneficial bacteria were enrolled into the study and randomly assigned to the different treatment groups: 14 received auto-FMT by enema and 11 received standard-of-care.
The patients who received auto-FMT consistently regained bacterial diversity, composition and function; recovery of beneficial bacteria in the 11 control patients was delayed.
The researchers are continuing to monitor the study patients to determine if auto-FMT improves patient outcomes, such as the incidence and severity of bacterial, viral and fungal infections and the incidence and severity of GVHD. Whether FMT from a healthy donor would be as beneficial as the patient’s own fecal sample at restoring beneficial bacteria remains to be studied.
Learn more: Fecal microbiota transplantation helps restore beneficial bacteria in cancer patients
The Latest on: Fecal microbiota transplantation
[google_news title=”” keyword=”fecal microbiota transplantation” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Fecal microbiota transplantation
- Hack Your Health: The Secrets of Your Gut on Netflix: Meet the Participantson May 1, 2024 at 9:18 am
Netflix recently released a documentary titled Hack Your Health: The Secrets of Your Gut. It delves into the importance of a healthy digestive system. Directed by Anjali Nayar, it was released on ...
- Global Functional Dyspepsia Drug Market to reach a valuation of US$ 16.4 billion by 2034, Future Market Insights, Inc. Projectionon May 1, 2024 at 3:30 am
Probiotics, prebiotics, and fecal microbiota transplantation are areas of exploration, offering potential for novel treatment options. Advancements in regenerative medicine, including tissue ...
- Fecal Transplant Shows Promise for Easing Inflammatory Bowel Disease Symptomson April 25, 2024 at 4:45 pm
For the study, scientists reviewed results from 15 clinical trials that tested fecal microbiota transplants (FMT) — when stool with healthy microorganisms is inserted into a sick patient’s digestive ...
- Belgian Man With Auto-Brewery Syndrome Acquitted Of Drunk Driving: How To Diagnose, Treat This Conditionon April 25, 2024 at 2:46 am
Auto Brewery Syndrome is a complex and often misunderstood condition that requires careful diagnosis and management ...
- Microbiome Alterations Link to Growth Hormone Deficiencyon April 19, 2024 at 4:56 am
Growth hormone deficiency appears to be linked to a particular microbiome signature that could help with the early diagnosis and treatment of short stature, suggest study.
- Breakthrough: Poo transplant can slow Parkinson’s symptomson April 13, 2024 at 4:00 am
Parkinson's motor symptoms were improved in a clinical study in which early-stage patients were given fecal transplants.
- News - Ferring Pharmaceuticalson August 24, 2023 at 11:03 am
Privately-held Swiss drugmaker Ferring Pharmaceuticals and Zürich-based microbiome translation company PharmaBiome have announced a research and development collaboration to drive forward new ...
via Bing News